Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations
作者： Marco P. Donadini , Mark Crowther
DOI: 10.1016/J.HOC.2010.05.005
关键词: Systemic disease 、 Cardiology 、 Coagulopathy 、 Thrombosis 、 Vascular disease 、 Internal medicine 、 Autoimmune disease 、 Thrombophilia 、 Pathology 、 Immunopathology 、 Antiphospholipid syndrome 、 Medicine
摘要: Antiphospholipid syndrome (APS) is a systemic disease that causes venous and arterial thrombosis in virtually any organ responsible for fetal losses pregnancy disorders. Previously, APS was thought to be present mainly patients with lupus erythematosus. The spectrum of clinical manifestations wide, because the thrombotic process may involve vessels size organ. At present, there no evidence support or refute specific treatment strategies primary prophylaxis thrombosis.
sci-hub.se 参考文章(44)
P Vila, M C Hernández, M F López-Fernández, J Batlle, Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects Thrombosis and Haemostasis. ,vol. 72, pp. 209- 213 ,(1994) , 10.1055/S-0038-1648840
S Pierangeli, F Segovia, C Ortega, I Palomo, Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. Clinical and Experimental Rheumatology. ,vol. 27, pp. 668- 677 ,(2009)
Cheng-De Yang, Kwan-Ki Hwang, Weihong Yan, Kerry Gallagher, John FitzGerald, Jennifer M Grossman, Bevra H Hahn, Pojen P Chen, None, Identification of Anti-Plasmin Antibodies in the Antiphospholipid Syndrome That Inhibit Degradation of Fibrin Journal of Immunology. ,vol. 172, pp. 5765- 5773 ,(2004) , 10.4049/JIMMUNOL.172.9.5765
Omid Safa, Charles T. Esmon, Naomi L. Esmon, Inhibition of APC anticoagulant activity on oxidized phospholipid by anti–β2-glycoprotein I monoclonal antibodies Blood. ,vol. 106, pp. 1629- 1635 ,(2005) , 10.1182/BLOOD-2005-01-0404
R A Asherson, The catastrophic antiphospholipid syndrome. The Journal of Rheumatology. ,vol. 19, pp. 508- 512 ,(1992) , 10.1007/978-3-319-11044-8_20
Wendell A. Wilson, Azzudin E. Gharavi, Takao Koike, Michael D. Lockshin, D. Ware Branch, Jean-Charles Piette, Robin Brey, Ronald Derksen, E. Nigel Harris, Graham R. V. Hughes, Douglas A. Triplett, Munther A. Khamashta, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis & Rheumatism. ,vol. 42, pp. 1309- 1311 ,(1999) , 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
N. DI SIMONE, M. P. LUIGI, D. MARCO, D. N. FIORELLA, D. SILVIA, D. M. CLARA, C. ALESSANDRO, Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature. Annals of the New York Academy of Sciences. ,vol. 1108, pp. 505- 514 ,(2007) , 10.1196/ANNALS.1422.054
Francisco López-Lira, Luis Rosales-León, Verónica Monroy Martínez, Blanca H. Ruiz Ordaz, The role of β2-glycoprotein I (β2GPI) in the activation of plasminogen Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. ,vol. 1764, pp. 815- 823 ,(2006) , 10.1016/J.BBAPAP.2005.12.020
Jacob H. Rand, Xiao-Xuan Wu, Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thrombosis Research. ,vol. 114, pp. 383- 389 ,(2004) , 10.1016/J.THROMRES.2004.07.021
G. FINAZZI, R. MARCHIOLI, V. BRANCACCIO, P. SCHINCO, F. WISLOFF, J. MUSIAL, F. BAUDO, M. BERRETTINI, S. Testa, A. D'ANGELO, G. TOGNONI, T. BARBUI, A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 848- 853 ,(2005) , 10.1111/J.1538-7836.2005.01340.X